[EN] OXAZOLE-DERIVATIVES AS PPAR AGONISTS<br/>[FR] DERIVES D'OXAZOLE UTILISES EN TANT QU'AGONISTES DE PPAR
申请人:PFIZER
公开号:WO2004074284A1
公开(公告)日:2004-09-02
Fused heteroaryl carboxylic acids of formula (I): wherein R1, Ar, A, Y, HET, Q, and T are as defined in the specification; pharmaceutical compositions containing effective amounts of said compounds or their salts are useful for treating PPAR related disorders, such as diabetes, dyslipidemia, obesity and inflammatory disorders.
式(I)的融合杂环羧酸:其中R1、Ar、A、Y、HET、Q和T如规范中定义;含有所述化合物或其盐的有效量的药物组合物对于治疗PPAR相关疾病,如糖尿病、血脂异常、肥胖和炎症性疾病是有用的。